Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

SIMPLE SUMMARY: The combination of disulfiram and copper is a novel anti-cancer drug under clinical development for the treatment of several tumor types including hepatocellular carcinoma. In this study, we investigated the potential of disulfiram and copper to induce immunogenic cell death and whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xingxing, Huang, Hechen, Pan, Caixu, Mei, Zhibin, Yin, Shengyong, Zhou, Lin, Zheng, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564202/
https://www.ncbi.nlm.nih.gov/pubmed/36230638
http://dx.doi.org/10.3390/cancers14194715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564202/
https://www.ncbi.nlm.nih.gov/pubmed/36230638
http://dx.doi.org/10.3390/cancers14194715

Ejemplares similares